Jingjing Li

8PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer diagnosisNeurogeneticsPredictive and prognostic markersGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 27, 2026
CXCL14 Inhibits Colon Cancer Progression by Modulating Tumor Cell Invasion and Immune Microenvironment.

|Oct 16, 2024
Insights of Expression Profile of Chemokine Family in Inflammatory Bowel Diseases and Carcinogenesis.

Yinjie Zhang, Yue Jin, Yanjing Wang

|Feb 10, 2024
CXCL14 as a Key Regulator of Neuronal Development: Insights from Its Receptor and Multi-Omics Analysis.

Yinjie Zhang, Yue Jin, Jingjing Li

|Feb 09, 2024
Stromal-derived MAOB promotes prostate cancer growth and progression.

Tianjie Pu, Jing Wang, Jing Wei

|Nov 25, 2023
Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter Methylation.

Yanjing Wang, Siyi Wang, Yuchen Niu

|Aug 19, 2022
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer.

Jing Wang, Jingjing Li, Lijuan Yin

Pageof 2

Frequent Collaborators

3 joint publications

Boyang Jason Wu

3 joint publications

Yanjing Wang

3 joint publications

Siyi Wang

3 joint publications

Buyong Ma